Friday October 20th 2017

[Comment] Trial and error in clinical studies: lessons from ATAMS

Multiple sclerosis is one of the most prevalent neurological diseases in young adults and causes progressive and permanent disability in about a third of patients. Thus a treatment that halts or, even better, reverses disease progression is desperately needed, but unfortunately is not on the horizon. Nevertheless, substantial progress has been made in research into the treatment of multiple sclerosis during the past 20 years. The consensus is that at least the majority of multiple sclerosis cases have an autoimmune pathogenesis, so existing treatment protocols focus mainly on immune modulation. (Source: Lancet Neurology)

Read this article: 

[Comment] Trial and error in clinical studies: lessons from ATAMS

Leave a Comment

More from category

OHSU’s Robertson on coming to grips with his diagnosis
OHSU’s Robertson on coming to grips with his diagnosis

After learning that he has multiple sclerosis, Dr. Joe Robertson was in denial. Then he realized there was no other [Read More]

Concussion in teens increase risk of multiple sclerosis
Concussion in teens increase risk of multiple sclerosis

Researchers from Orebro University in Sweden studied the connection between concussions and multiple sclerosis. They [Read More]

Phys Ed: Concussions in Teenagers Tied to Multiple Sclerosis Risk
Phys Ed: Concussions in Teenagers Tied to Multiple Sclerosis Risk

A large-scale new study found that concussions in adolescents can increase the risk of later developing multiple [Read More]

Multiple sclerosis: Oligodendrocytes from stemmcells
Multiple sclerosis: Oligodendrocytes from stemmcells

(Heinrich-Heine University Duesseldorf) A scientific collaboration between stem cell researchers of the [Read More]

Global Experts Publish Recommendations for Overcoming Challenges to Improve Clinical Trials in Progr
Global Experts Publish Recommendations for Overcoming Challenges to Improve Clinical Trials in Progr

/About-the-Society/News/Global-Experts-Publish-Recommendations-for-Overcom [Read More]